Statins have also been associated with heightened systemic inflammation, characterized by elevated levels of pro-inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbate insulin resistance [12]. This evidence concerns the gene IL6 and Insulin resistance.